Enveric Biosciences SG&A Expense (Quarterly) Insights

Enveric Biosciences Inc (ENVB)

0.935 +0.01 (+0.56%) USD | NASDAQ | May 02, 16:00

0.935 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1996. Upgrade now.

Date	Value
December 31, 2023	2.779M
September 30, 2023	2.010M
June 30, 2023	3.155M
March 31, 2023	2.784M
December 31, 2022	2.822M
September 30, 2022	3.514M
June 30, 2022	2.501M
March 31, 2022	2.768M
December 31, 2021	10.46M
September 30, 2021	2.124M
June 30, 2021	2.309M
March 31, 2021	6.769M
December 31, 2020	4.165M
September 30, 2020	0.4265M
June 30, 2020	0.7166M
March 31, 2020	2.924M
December 31, 2019	3.135M
September 30, 2019	2.902M
June 30, 2019	3.296M
March 31, 2019	2.877M
December 31, 2018	2.735M
September 30, 2018	2.656M
June 30, 2018	2.525M
March 31, 2018	2.879M
December 31, 2017	4.950M

Date	Value
September 30, 2017	5.686M
June 30, 2017	4.840M
March 31, 2017	3.034M
December 31, 2016	3.644M
September 30, 2016	1.463M
June 30, 2016	2.113M
March 31, 2016	1.750M
September 30, 2015	1.497M
June 30, 2015	0.4897M
March 31, 2015	0.0023M
December 31, 2014	0.0104M
September 30, 2014	0.0031M
June 30, 2014	0.0117M
March 31, 2014	0.0076M
December 31, 2013	0.0141M
September 30, 2013	0.0046M
June 30, 2013	0.0039M
March 31, 2013	0.0047M
December 31, 2012	0.01M
September 30, 2012	0.0046M
June 30, 2012	0.0041M
March 31, 2012	0.004M
December 31, 2011	0.013M
September 30, 2011	0.0037M
June 30, 2011	0.0036M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.4265M

Minimum

Sep 2020

10.46M

Maximum

Dec 2021

3.240M

Average

2.822M

Median

Dec 2022

SG&A Expense (Quarterly) Benchmarks